Real-world study reports promising first-line orelabrutinib outcomes in CLL/SLL
A retrospective single-center study of 75 treatment-naive CLL/SLL patients reports an 86.7% response rate with frontline orelabrutinib monotherapy and no ...
Tag: small lymphocytic lymphoma
POPULAR NEWS
-
Optical Hydrogen Sensor Built on Planar Lightwave Circuit Detects Leaks Without Electricity
-
L-Arginine Supplementation Boosts Amino Acid Digestibility in Heat-Stressed Pigs
-
U-Net Variants Compared for Automated Lung Tumor Segmentation on CT Scans
-
Flowing Water Weakens Layered Sandstone More Than Still Water, Study Finds